Insect peptides with improved protease-resistance protect mice against bacterial infection.
about
Peptides and Peptidomimetics for Antimicrobial Drug DesignAllosteric Coupling between the Lid and Interdomain Linker in DnaK Revealed by Inhibitor Binding StudiesRational design of novel peptidic DnaK ligands.Solution structure of microcin J25, the single macrocyclic antimicrobial peptide from Escherichia coli.Peptide-based Antifungal Therapies against Emerging Infections.Biochemical characterization of an anti-Candida factor produced by Enterococcus faecalisIn vivo efficacy of anuran trypsin inhibitory peptides against staphylococcal skin infection and the impact of peptide cyclizationBabesial vector tick defensin against Babesia sp. parasites.Design of a functionally equivalent nonglycosylated analog of the glycopeptide antibiotic formaecin I.Antimicrobial peptides with cell-penetrating peptide properties and vice versa.Proline-rich antimicrobial peptides: converging to a non-lytic mechanism of action.Mechanism of Escherichia coli resistance to Pyrrhocoricin.Synergistic effects of the membrane actions of cecropin-melittin antimicrobial hybrid peptide BP100Oncocin Onc72 is efficacious against antibiotic-susceptible Klebsiella pneumoniae ATCC 43816 in a murine thigh infection model.Mechanisms of biofilm inhibition and degradation by antimicrobial peptides.Activity of levofloxacin alone and in combination with a DnaK inhibitor against gram-negative rods, including levofloxacin-resistant strains.Glycosylated analogs of formaecin I and drosocin exhibit differential pattern of antibacterial activity.Identification of crucial residues for the antibacterial activity of the proline-rich peptide, pyrrhocoricin.Antimicrobial Peptides As Biologic and Immunotherapeutic Agents against Cancer: A Comprehensive Overview.Interaction of protamine with gram-negative bacteria membranes: possible alternative mechanisms of internalization in Escherichia coli, Salmonella typhimurium and Pseudomonas aeruginosa.Evaluation of the antibacterial spectrum of drosocin analogues.Targeting the Proteostasis Network for Mycobacterial Drug Discovery.Monitoring the interference of protein-protein interactions in vivo by bimolecular fluorescence complementation: the DnaK case.
P2860
Q26799959-74F44A4D-C1FB-4294-B93D-84AF6D496DC9Q27653249-CE782A70-2222-4008-9272-AC2AE83992A0Q30318620-56C2F03A-4B93-4CE2-BFD2-A32499558620Q30661418-E2A3F649-0559-454E-9519-BFA74BB58CEDQ33862289-5ED638BF-79A3-4B2E-838F-C18ED14A61D6Q34325020-B3EC5F91-D272-4C6E-907D-ABBFB81AF314Q35169096-1F41429E-F7F8-474F-922D-90751FCF50FEQ35913632-A59D9471-D9F2-400C-8067-CCA9B62697D0Q36388148-9476EF19-F7D3-490E-B2E0-0425A89EDA11Q37845172-DC80A693-D525-4E9E-8E49-30ED94C32281Q37877177-5AFD09B8-7557-48B4-BC86-61ED68784796Q38848631-64FA9733-A943-4DD9-89F8-BD9F561583C9Q39878043-8AAB4D29-D077-4067-A2CB-00272F4945DDQ41236257-3605DC3E-4C21-46E9-B8E6-20A56CD25123Q41242922-E937CA57-0D9C-4A54-B377-6F3DC347F726Q41949708-C24F69BD-096C-45E8-A440-77FEB4CBEDC7Q44063337-5CB28B09-9829-4C5D-8805-507F4C96E05DQ44117220-6B11FB31-F4AF-4622-A644-DCCAD0652F37Q45891664-0E7055F4-97A5-4E45-8354-69C3CB818BB2Q50002887-FD2B6AA9-F7E8-40FD-9C18-54FC46B1EEF5Q50076014-598BDDE0-8C49-4926-B897-7479B3F6306BQ52692190-D2232AF3-AC5E-4416-B077-93CC9C88C31FQ52693279-F2644AF7-62A1-433B-B24E-DA88CC401308
P2860
Insect peptides with improved protease-resistance protect mice against bacterial infection.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Insect peptides with improved ...... e against bacterial infection.
@en
Insect peptides with improved ...... e against bacterial infection.
@nl
type
label
Insect peptides with improved ...... e against bacterial infection.
@en
Insect peptides with improved ...... e against bacterial infection.
@nl
prefLabel
Insect peptides with improved ...... e against bacterial infection.
@en
Insect peptides with improved ...... e against bacterial infection.
@nl
P2093
P2860
P356
P1433
P1476
Insect peptides with improved ...... e against bacterial infection.
@en
P2093
A M McManus
R Hoffmann
P2860
P304
P356
10.1110/PS.9.4.742
P577
2000-04-01T00:00:00Z